We further studied the expression of PART-1 in 27 paired (from the same patient) cancerous and non-cancerous prostatic tissues, with qualitative and quantitative RT-PCR (LightCycler®technology), in order to examine whether PART-1 is overexpressed or underexpressed in cancer. This evidence concerns the gene PART1 and cancer.